Community Based Strategies for Early Detection of Melanoma

Study Purpose

The purpose of this study is to pilot the use of community education and digital dermatology to increase the early detection of curable melanomas.

Recruitment Criteria

Accepts Healthy Volunteers Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms	Yes
Study Type An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies.	Observational
Eligible Ages	18 Years and Over
Gender	All

More Inclusion & Exclusion Criteria

Inclusion Criteria:

- 18 years and older.

- >1mm lesion thickness with ulceration (T2b) or >2mm lesion thickness (T3/T4) - Low socioeconomic status (SES) Non-Latinx White individuals (according to Yost's index SES level based on a principal components analysis) - Latinx individuals.

- Individual resides in semi-rural area, including zip codes within Antelope Valley in Southern California and Salinas in Northern California.

- Individual speaks and reads English or Spanish.

- Voluntary willingness and comprehension to consent.

Exclusion Criteria:

Exclusion criteria is stage 0, I, IV, or unstaged diagnosis, or any individual who does not meet the above stated eligibility criteria will be excluded from the study.

Trial Details

Trial ID: This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.	NCT04799106
Phase Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
Lead Sponsor The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.	Cedars-Sinai Medical Center
Principal Investigator The person who is responsible for the scientific and technical direction of the entire clinical study.	Robert Haile, DrPH, MPH
Principal Investigator Affiliation	Cedars-Sinai
Agency Class Category of organization(s) involved as sponsor (and collaborator) supporting the trial.	Other
Overall Status	Not yet recruiting
Countries
Conditions The disease, disorder, syndrome, illness, or injury that is being studied.	Melanoma

Contact Information

This trial has no sites locations listed at this time. If you are interested in learning more, you can contact the trial's primary contact:

Hayden Hutchison, MSW, MPH

hayden.hutchison@cshs.org

310-423-2361

For additional contact information, you can also visit the trial on clinicaltrials.gov.

Clinical Trial Finder